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Background: An association between eosinophilic esophagitis (EoE) and celiac disease (CD) has been suggested in
the literature. Our aim was to confirm and quantify the association between these two diseases.
Methods: All patients in a large Canadian city diagnosed with EoE or CD over a five-year period were identified.
Standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were calculated.
Results: Over the five-year study EoE was diagnosed in 421 patients and CD was diagnosed in 763 patients. The
incidence of EoE ranged from 2.1 to 10.7 cases per 100,000 population. The incidence of CD ranged from 10.4 to
15.7 cases per 100,000 population. Among the EoE cohort, 83 (20%) cases of EoE and 245 (32%) cases of CD were
diagnosed in pediatric patients. The incidence of EoE in the pediatric subpopulation ranged from 3.7 to 6.9 cases
per 100,000 population. The incidence of CD in the pediatric subpopulation ranged from 9.5 to 22.7 cases per
100,000 population. The concomitant diagnosis of both EoE and CD was made in three patients, all of whom were
pediatric males. The SIR for EoE in the CD cohort was 48.4 (95% CI = 9.73, 141.41) with a SIR for CD within the
paediatric EoE cohort of 75.05 (95% CI = 15.08, 219.28).
Conclusions: This study confirms the association between EoE and CD. However, this association may be limited to
pediatrics where the risk of each condition is increased 50 to 75-fold in patients diagnosed with the alternative
condition. The concomitant diagnosis of these conditions should be considered in pediatric patients with upper
gastrointestinal symptoms.
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ratiosIntroduction
Eosinophilic esophagitis (EoE) and celiac disease (CD)
are distinct entities affecting the upper gastrointestinal
tract, with different clinical and histopathological fea-
tures. Although eosinophilic infiltration of the esophagus
was first described in the late 1970s, it was not until
1993 that EoE was proposed as a distinct clinicopatho-
logic syndrome [1]. Originally thought to be an uncom-
mon condition, its incidence has dramatically risen over
the past decade, recently estimated at 4.4 to 9.5 cases
per 100,000 person-years [2,3]. When first described,
EoE was felt to be a predominantly pediatric condition,
however, it is now commonly diagnosed in adults as well
as children [4]. There is a striking male predominance* Correspondence: gidoc@gmx.com
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reproduction in any medium, provided the orwith 76% of adult and 66% of pediatric cases being diag-
nosed in males [5].
The pathogenesis of EoE is not completely understood
but appears to involve an interplay between genetic fac-
tors and environmental exposures. An association be-
tween EoE and allergic disorders such as asthma, atopic
dermatitis, and food and environmental allergies has
been long established [6-10]. Genome wide association
studies (GWAS) have identified a number of single- nu-
cleotide polymorphisms (SNPs) that appear to confer
susceptibility to EoE [11,12]. In one pivotal study, a SNP
in the gene that codes eotaxin-3, a cytokine critical to
eosinophil migration, was associated with susceptibility
to EoE [11]. Another GWAS has implicated over-
expression of the gene that codes for thymic stromal
lymphopoietin (TSLP) as an important factor in disease
development. Interestingly, TSLP is a cytokine thatl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in other inflammatory conditions including asthma, in-
flammatory arthritis, and atopic dermatitis [13-15].
Celiac disease is an autoimmune enteropathy that has
been estimated to affect up to one percent of the general
population, although many remain undiagnosed [16].
Recent incidence estimates range from 2 to 17.4 cases
per 100,000 population [17-20]. The clinical features can
be rather non-specific but malabsorptive features domin-
ate in the form of diarrhea, iron-deficiency anemia and
weight loss; in childhood there is failure to thrive and
growth retardation [21,22]. While CD was also once
considered a childhood disease, the majority of cases are
now discovered in adulthood with an average age of
diagnosis of 46 years [21].
The development of CD is triggered by enteric expos-
ure to the protein composite gluten in genetically
predisposed individuals. The implicated genes at the
HLA-DQ2 and/or DQ8 gene loci are found in 95 per-
cent of people with celiac disease [23-25]. Recent gen-
ome wide studies have identified genes that convey
overlapping susceptibility for a number of immune me-
diated conditions, including CD, type 1 diabetes, and
Crohn’s disease [26]. To date, there have been no SNPs
identified that would suggest a common genetic basis
for EoE and CD. Furthermore, the frequency of HLA al-
leles associated with CD are no more common in adults
with EoE than the general population [27].
The apparent absence of a genetic connection between
EoE and CD is especially interesting given a clinical as-
sociation that has been suggested in recent years. The
first such reports were case studies of pediatric patients
concomitantly diagnosed with both EoE and CD [28-31].
Two retrospective, cohort studies from Australia subse-
quently found a higher than expected prevalence of EoE
among pediatric patients with CD. Leslie et al. [32]
reviewed the medical records of 250 children with histo-
logically confirmed CD over a seven-year period; 10 had
been concurrently diagnosed with EoE. In a similar
study, Ooi et al. [33] found that 7 of 221 children with
CD had also been diagnosed with EoE. The estimated
prevalence of EoE in these two pediatric CD cohorts was
4.0% and 3.2%, respectively. This is markedly higher than
the 0.009% prevalence rate (0.9 per 10,000) reported for
EoE in the general pediatric population [34]. Thompson
et al. [35] recently reported on a cohort of 1142 adult
and 297 pediatric CD patients presenting to a specialized
CD referral centre in New York City and found an over-
all Standardized Incidence Ratio (SIR) for EoE of 16.0
using EoE incidence data from an Olmsted County
population.
The incidence of autoimmune diseases of the gastro-
intestinal tract is increasing and despite excellent on-
going research the reason(s) remains unclear. As this isespecially true of EoE and CD, we felt that it was of par-
ticular importance to confirm the association between
EoE and CD using population-based pathology data.
Given that the putative association has been mainly de-
scribed in pediatric populations, we also sought to deter-
mine if this association extends to adults.
Methods
We undertook a population-based review of all patients
diagnosed with CD and EoE within a large Canadian
centre. The Calgary Health Region (CHR) is the sole
provider of all medical and surgical services for 1.2 mil-
lion people, 300,000 of whom are younger than 19 years
[36]. A centralized laboratory and pathology service
processes all adult and pediatric endoscopic biopsy
specimens and generates histopathology reports that
are stored in a searchable database. A keyword search
was used to identify all duodenal and esophageal biop-
sies obtained within the CHR between January 1, 2004
and December 31, 2008. These pathology reports were
then reviewed to determine if histological evidence of
EoE or CD was present. For this review we defined the
pediatric subpopulation as all persons younger than
19 years of age.
Eosinophilic esophagitis is a clinicopathological diag-
nosis based on the presence of typical symptoms and an
esophageal biopsy demonstrating greater than 15 eosino-
phils per HPF [5]. Cases of EoE within our study popula-
tion were identified by histopathology reports stating
that the biopsy was consistent with or diagnostic of EoE.
The diagnosis of CD was based on duodenal biopsies
demonstrating typical histopathological features and
classified using the modified Marsh criteria [37]. In gen-
eral, biopsies demonstrating Marsh stage 2, 3a-c, and 4
lesions are diagnostic of CD. Marsh stage 1 biopsies are
less specific and only considered to represent CD in the
setting of a positive serological marker. (e.g. elevated
anti-tissue transglutaminase). At the time of this study
there where no formal requirements for pathology re-
porting of duodenal specimens, therefore, pathology re-
ports that did not specify a Marsh stage were considered
positive for CD when the pathologist commented that
the biopsies were consistent with, or diagnostic of CD.
Serologic confirmation of CD was obtained if pathologist
comments were indeterminate (e.g. Marsh stage I lesions)
and determined to represent a positive case of CD is a
serologic marker was consistent with the diagnosis of CD
and negative if the serology was normal or unavailable.
Statistical analysis
Crude incidence rates were calculated using CHR popu-
lation data for the years 2004–2008 [36]. Crude inci-
dence rates were age- and gender-adjusted using the age
and gender distribution of the 2006 Canadian population
AB
Figure 1 The Incidence of Celiac disease and eosinophilic
esophagitis. Panel A) shows the incidence of both Celiac disease
and eosinophilic esophagitis in males, per 100,000 population, age-
and gender- adjusted, by year. Panel B) shows the incidence of
Celiac disease and eosinophilic esophagitis in females, per 100,000
population, age- and gender- adjusted, by year.
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performed in order to mitigate the effect of any regional
variability in age and gender distribution.
To quantify a relationship between EoE and CD, SIRs
with 95% confidence intervals (CIs) were calculated [39].
A SIR is an estimate of the true occurrence of disease in
a population relative to what might be expected based
on incidence rates in an average (“general”) population.
The ratio comes from dividing the observed number
diagnosed (the number of cases of a specific disease)
within a reference population by the expected number
within the general population. A SIR greater than unity
(1.0) would indicate a higher than expected number of
cases within the reference population as compared to
the “general” population.
This study was approved by the Conjoint Health Re-
search Ethics Board at the University of Calgary and is
in agreement with the Declaration of Helsinki.
Results
Over the five-year study period 421 patients were diag-
nosed with EoE. The age- and gender-adjusted in-
cidence of EoE ranged from 2.1 cases per 100,000
population in 2004 to 10.7 cases per 100,000 population
in 2008 (Table 1). As previously reported, over the same
time period 763 patients were diagnosed with CD [17].
The age- and gender-adjusted incidence of CD ranged
from 10.4 per 100,000 population in 2004 to 15.7 per
100,000 population in 2007 (Table 1).
When we looked at the gender distribution within the
EoE and CD cohorts we found a significant male predom-
inance for EoE with 82% (344) of patients being male. In
contrast, within the CD cohort the opposite was true, only
32% (241) of patients were male (Figure 1).
Both conditions were commonly diagnosed in the
pediatric age group. Among the EoE cohort, 83(20%)
cases were diagnosed in patients younger than 19 years
of age and within the CD cohort 245 (32%) cases were
diagnosed in patients younger than 19 years of age. The
age- and gender-adjusted incidence of EoE within the
pediatric subpopulation ranged from 3.7 to 6.9 cases per
100,000 population. The age- and gender-adjustedTable 1 Incidence of celiac disease and eosinophilic
esophagitis, per 100,000 population, age- and gender-
adjusted, by year
2004 2005 2006 2007 2008
Celiac disease
Total population 10.4 10.7 13.0 15.7 14.0
Pediatric subpopulation 9.5 18.4 16.3 22.7 16.0
Eosinophilic esophagitis
Total population 2.1 5.0 7.2 9.4 10.7
Pediatric subpopulation 6.6 6.9 3.7 6.3 4.6incidence of CD within the pediatric subpopulation
ranged from 9.5 to 22.7 cases per 100,000 (Table 1).
The diagnosis of both EoE and CD was made in three
patients, all of whom were males in the pediatric age
group. No adults were diagnosed with both conditions.
The pertinent clinical, endoscopic and histological de-
tails are summarized in Table 2. Patient #1 was diag-
nosed with both conditions after presenting with a food
bolus obstruction. At the time of EoE diagnosis the pa-
tient was on proton pump inhibitor (PPI) therapy and
had a near-normal pH study. The diagnosis of CD was
made by positive CD serology and Marsh III lesions on
histology that normalized in response to a gluten-free
diet. Patient #2 presented with abdominal pain and re-
flux and was diagnosed with EoE by the presence of the
typical endoscopic and histologic findings. It is not clear
if this patient was on a PPI or underwent a pH study.
The diagnosis of CD was made by the presence of Marsh
Table 2 Clinical, histological, and endoscopic findings in patients diagnosed with both eosinophilic esophagitis (EoE)
and celiac disease (CD)
Patient # 1 Patient # 2 Patient # 3
Symptoms Food bolus obstruction and heartburn Abdominal pain and reflux Intermittent vomiting
Age at diagnosis 14 EoE / 14 CD 15 EoE / 15 CD 11 EoE / 11 CD
pH study Normal – Normal
PPI Yes – Yes
Other diagnoses Asthma, allergies – Atopy, food allergies
Endoscopy findings
Esophagus Nodular mucosa and linear furrowing Linear furrowing and adherent white plaques Linear furrowing
Duodenum “Scalloping” of the duodenum Normal Normal
Histology findings
Esophagus >15 EoE per HPF >15 EoE per HPF >15 EoE per HPF
Duodenum Marsh III Marsh IIIb Marsh III
Gluten restriction Normalized Improved Normalized
PPI, proton pump inhibitor.
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sponse to gluten-free diet. Patient #3 presented with
intermittent vomiting and at the time of EoE diagnosis
he was on PPI therapy and had a near-normal pH study.
The diagnosis of CD was made by positive serology and
Marsh III lesions on histology. Repeat duodenal biopsies
while on a gluten free diet showed mild villous blunting,
however, CD serology normalized. None of the patients
had evidence of gastric or duodenal eosinophilia on
histology.
The SIR for EoE within the pediatric CD cohort was
48.4 (95% CI = 9.73, 141.41). Conversely, the SIR for CD
within the paediatric EoE cohort was 75.1 (95% CI =
15.08, 219.28). These SIRs imply that the concurrent
diagnosis of EoE and CD in late childhood/adolescence
occurred at a rate 48 to 75 times greater than predicted
by incidence rates in the same population.
Discussion
Celiac disease and EoE are two clinically, anatomically,
and histologically distinct disorders of the upper gas-
trointestinal tract. An association between EoE and CD
has been previously suggested. Contrary to what we
expected to find in the current population-wide analysis
that included a robust number of adults, this association
may be solely a pediatric phenomenon. Although the
overall number of patients with EoE and CD was low,
no adults were diagnosed with both conditions, even
though the majority of patients diagnosed with either
condition were adults. Further, all three cases of EoE
and CD were male. Although EoE is a predominantly
male condition, CD is a predominantly female condition.
In contrast to our findings, the Australian reports found
that less than half of their patients with both diagnoses
were males [32,33].This study confirms the association between EoE and
CD in pediatric patients. The prevalence of EoE in our
five-year pediatric CD cohort was somewhat lower than
reported in two previous studies despite our pediatric
CD cohort being much larger than the previous studies
(1.2% vs. 3.2% and 4.0%) [32,33]. It was, however, similar
to the prevalence described in the New Your City CD
cohort (0.97%) [35]. It is difficult to compare these re-
sults directly, or to other published prevalence rates, and
it should be stressed that extracting prevalence estimates
from a limited cohort identified by only five-years of in-
cidence data undoubtedly underestimates the true preva-
lence of a disease within a population. Thus, we have
presented SIRs to assess the association between EoE
and CD. These SIRs provide a conservative estimate of
the degree of association as they relay on a patient being
diagnosed with both conditions within the five-year
study period. Our somewhat lower rate of concomitant
diagnosis does raise the possibility that coexistent EoE
and CD might have been under-diagnosed in our study
population, especially given the high incidence of auto-
immune gastrointestinal illnesses in general within our
population.
Importantly, the disease incidence rates we present
in this paper compare favourably to those published
from elsewhere in North America. In a recent study
from Olmsted County, Ludvigsson and colleagues re-
port the average CD incidence of 17.4 cases per100,000
person-years [20]. This is comparable to the CD inci-
dence we present in this paper, which ranged from 10.4
to 15.7 cases per 100,000 population. A similar paper
also from Olmsted County reported the incidence of
EoE to be 9.45 cases per 100,000 person years [3]. This
is equally comparable to the EoE incidence rates we re-
port that demonstrate a steady increase from 2.1 to
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study period.
A limitation in this study relates to the clinicopatho-
logic diagnosis of EoE. The clinical information was not
available and diagnosis was based solely on established
histopathologic features of EoE. The presence of tissue
eosinophilia can be seen in the setting of other gastro-
intestinal diseases, although usually eosinophil density is
greater than 15 per HPF [40,41]. At the least, gastric
eosinophilia was eliminated as all three patients diag-
nosed with EoE and CD had concurrent gastric biopsies
that were normal. While we have demonstrated im-
provement or normalization of duodenal biopsies after
initiating a gluten free diet, we cannot comment on the
response of esophageal eosinophilia to gluten restriction.
The retrospective design of the current study did limit
the availability of certain data which could have added to
our analysis, including the total number and location of
biopsies obtained from each patient, the symptoms that
prompted the endoscopic investigation, and the response
to therapy. It is conceivable that a patient undergoing an
upper endoscopy for one condition may be more likely
to be indecently diagnosed with another condition. It is
also possible that pediatric gastroenterologists perform
more routine biopsies of normal appearing mucosa than
their adult colleagues. Both of these issues could serve
to generate detection bias when it comes to the diagno-
sis of both conditions and emphasizes the need of future
prospective studies.
Another limitation of this study is that we only
assessed data over a five-year period. We were unable to
determine if any of the patients had a previous histo-
logical diagnosis of CD or EoE prior to 2004 or from an-
other jurisdiction. This issue could potentially result in
an overestimation of the true incidence, however, it
would also serve to underestimate the degree of disease
association.Conclusion
The incidence of autoimmune diseases of the gastrointes-
tinal tract is increasing. Although no genetic link between
CD and EoE has been identified, this population-based
study confirms the association between EoE and CD. The
estimated risk of each condition is increased 50 to 75-fold
in those pediatric patients diagnosed with the alternative
condition. Furthermore, our data suggest that this signifi-
cant association may be limited to the pediatric age group;
no adults diagnosed with both conditions were identified.
This unexpected finding highlights the urgent need for
prospective studies in both children and adults. The major
implication of this study is that the concomitant diagnosis
of these conditions should be considered in pediatric pa-
tients with upper gastrointestinal symptoms.Abbreviations
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